150 related articles for article (PubMed ID: 33902413)
1. Outcome of a HIV Positive Patient Infected with COVID-19 After an Autologous Bone Marrow Transplantation: A Case Report.
Mardani M; Sharifi-Razavi A; Sheibani S; Baziboroun M
Curr HIV Res; 2021; 19(4):377-382. PubMed ID: 33902413
[TBL] [Abstract][Full Text] [Related]
2. Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient.
Lanzafame M; Lattuada E; Nicolè S; Rigo F; Cucchetto G; Concia E; Vento S
Int J STD AIDS; 2017 Jun; 28(7):726-728. PubMed ID: 27789848
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
Ryom L; Lundgren JD; El-Sadr W; Reiss P; Kirk O; Law M; Phillips A; Weber R; Fontas E; d' Arminio Monforte A; De Wit S; Dabis F; Hatleberg CI; Sabin C; Mocroft A;
Lancet HIV; 2018 Jun; 5(6):e291-e300. PubMed ID: 29731407
[TBL] [Abstract][Full Text] [Related]
5. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
6. An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report.
Tian C; Tang L; Wu J; Li W; Ming X; Zhou H; Wu W; Zeng X
Ann Palliat Med; 2021 May; 10(5):5808-5812. PubMed ID: 32787378
[TBL] [Abstract][Full Text] [Related]
7. Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial.
Galli L; Spagnuolo V; Bigoloni A; D'Arminio Monforte A; Montella F; Antinori A; Di Biagio A; Rusconi S; Guaraldi G; Di Giambenedetto S; Borderi M; Gibellini D; Caramatti G; Lazzarin A; Castagna A;
J Antimicrob Chemother; 2016 Jun; 71(6):1637-42. PubMed ID: 26945711
[TBL] [Abstract][Full Text] [Related]
8. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
Costagliola D; Potard V; Lang S; de Castro N; Cotte L; Duval X; Duvivier C; Grabar S; Mary-Krause M; Partisani M; Ronot-Bregigeon S; Simon A; Tattevin P; Weiss L; Zucman D; Katlama C; Raffi F; Boccara F
J Infect Dis; 2020 Feb; 221(4):516-522. PubMed ID: 31828320
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.
Mondi A; Cimini E; Colavita F; Cicalini S; Pinnetti C; Matusali G; Casetti R; Maeurer M; Vergori A; Mazzotta V; Gagliardini R; De Zottis F; Schininà V; Girardi E; Puro V; Ippolito G; Vaia F; Capobianchi MR; Castilletti C; Agrati C; Antinori A
J Med Virol; 2021 Mar; 93(3):1796-1804. PubMed ID: 32975842
[TBL] [Abstract][Full Text] [Related]
10. Atazanavir exposure is effective during pregnancy regardless of tenofovir use.
Colbers A; Hawkins D; Hidalgo-Tenorio C; van der Ende M; Gingelmaier A; Weizsäcker K; Kabeya K; Taylor G; Rockstroh J; Lambert J; Moltó J; Wyen C; Sadiq ST; Ivanovic J; Giaquinto C; Burger D;
Antivir Ther; 2015; 20(1):57-64. PubMed ID: 24992294
[TBL] [Abstract][Full Text] [Related]
11. Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis.
Tigabu BM; Agide FD; Mohraz M; Nikfar S
Afr Health Sci; 2020 Mar; 20(1):91-101. PubMed ID: 33402897
[TBL] [Abstract][Full Text] [Related]
12. Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study.
Tsai MS; Chang SY; Lin SW; Kuo CH; Sun HY; Wu BR; Tang SY; Liu WC; Su YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Dec; 50(6):789-797. PubMed ID: 26857335
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients.
Biagi M; Badowski ME; Chiampas T; Young J; Patel M; Vaughn P
Int J STD AIDS; 2017 Jul; 28(8):766-772. PubMed ID: 27587601
[TBL] [Abstract][Full Text] [Related]
14. Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study.
d'Ettorre G; Ceccarelli G; Zaccarelli M; Ascoli-Bartoli T; Bianchi L; Bellelli V; De Girolamo G; Serafino S; Giustini N; Mastroianni CM; Vullo V
Int J STD AIDS; 2016 Jul; 27(8):638-43. PubMed ID: 26068963
[TBL] [Abstract][Full Text] [Related]
15. Second autologous bone marrow transplantation in Hodgkin's disease.
Avalos BR; Copelan EA
Bone Marrow Transplant; 1993 Dec; 12(6):665-7. PubMed ID: 8136752
[TBL] [Abstract][Full Text] [Related]
16. Atazanavir and chest pain.
Phillips M; Saxon C; Lee V
Int J STD AIDS; 2014 May; 25(6):461-4. PubMed ID: 24108452
[TBL] [Abstract][Full Text] [Related]
17. Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study.
Lombardi F; Belmonti S; Fabbiani M; Borghetti A; Cauda R; De Luca A; Di Giambenedetto S
J Antimicrob Chemother; 2016 Dec; 71(12):3621-3622. PubMed ID: 27494930
[No Abstract] [Full Text] [Related]
18. Hodgkin's lymphoma as a cause of fever of unknown origin in HIV infection.
Gérard L; Oksenhendler E
AIDS Patient Care STDS; 2003 Oct; 17(10):495-9. PubMed ID: 14588089
[TBL] [Abstract][Full Text] [Related]
19. Atazanavir/ritonavir: a review of its use in HIV therapy.
von Hentig N
Drugs Today (Barc); 2008 Feb; 44(2):103-32. PubMed ID: 18389089
[TBL] [Abstract][Full Text] [Related]
20. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]